Earnings reports to watch next week: GME, LOW, CRM >>> READ MORE
Portfolio Grader
Portfolio Grader (RSS)

Louis Navellier’s Portfolio Grader tool uses two critical characteristics to rank stocks.

Read complete bio
Recent Articles

Merck & Co (MRK) a Sell on Falling Industry Group Rank

Nov. 17, 2017, 1:00 pm EST – Portfolio Grader currently ranks Merck & Co (NYSE:MRK) a Sell. The approach to investing incorporated in this analytical tool developed by Louis Navellier assesses and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. MRK has maintained this ranking for the last month. More 

DowDuPont (DWDP) Sees Rating Decline….. Weak Earnings Visibility

Nov. 17, 2017, 12:45 pm EST – The current recommendation of Hold for DowDuPont Inc (NULL:DWDP) is the result of using Louis Navellier's approach to investing and his Portfolio Grader stock evaluator. The shares have been downgraded from a Buy to a Hold in the last week. More 

Earnings Visibility Restrict Verizon (VZ) Rating

Nov. 17, 2017, 12:30 pm EST – Verizon Communication Inc (NYSE:VZ) is one of 45 companies within the Diversified Telecommunication Services GICS industry group, which is in turn part of the 66 company GICS Telecommunication Services sector. VZ has a market value of $183.1 billion which is in the top decile in its industry group. The current Portfolio Grader ranking for VZ puts it 32 among the 45 companies in this industry group, giving it a lower than average position; in the third quartile of the sector with a ranking of 48 among the 66 companies in the sector, and number 2,974 in the nearly 5,000 company Portfolio Grader universe. More 

Improving Quant Score Metrics Drive Ranking of Novartis AG (NVS) to Buy

Nov. 17, 2017, 12:15 pm EST – The current recommendation of Buy for Novartis AG (NYSE:NVS) has been derived by using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. The shares have been upgraded from a Hold to a Buy in the last week. More 

Pfizer (PFE) a Hold on Pallid Sales Growth

Nov. 17, 2017, 12:00 pm EST – Pfizer Inc (NYSE:PFE) is a $209.7 billion in market value component of the Pharmaceuticals GICS industry group where the ranking for PFE by Portfolio Grader places it 44 among the 132 companies in this industry group, placing it in the top half. PFE is ranked in the top half of the sector with a ranking of 286 among the 782 companies in the sector and number 1,779 in the 5000 company Portfolio Grader company universe. More 

Sagging Industry Group Rank Make AT&T (T) a Sell

Nov. 17, 2017, 11:45 am EST – AT&T Inc (NYSE:T) is ranked as a Sell using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing system. This represents no change from the previous week and is the same ranking T has had from Portfolio Grader for the last month. More 

Robust Quant Score Metrics Drive Upgrade of China Mobile (CHL) to Buy

Nov. 17, 2017, 11:30 am EST – Portfolio Grader currently ranks China Mobile Ltd (NYSE:CHL) a Buy. With unique fundamental and quantitative metrics developed by Louis Navellier, this analytical tool evaluates nearly 5,000 stocks weekly. The shares have been upgraded from a Hold to a Buy in the last week. More 

Sales Growth Make Chevron (CVX) a Buy

Nov. 17, 2017, 11:15 am EST – Chevron Corp (NYSE:CVX) is one of 290 companies within the Oil Gas & Consumable Fuels GICS industry group, which is in turn part of the 363 company GICS Energy sector. CVX's market value is $222.6 billion which places it in the top 10% of its industry group. Currently, the stock's Portfolio Grader ranking places it 51 among the 290 companies in this industry group, placing it among the leaders; in the top quartile of the sector with a ranking of 58 among the 363 companies in the sector, and number 1,174 in the nearly 5,000 company Portfolio Grader universe. More 

Pallid Industry Group Rank Penalize Exxon Mobil (XOM) Rating

Nov. 17, 2017, 11:00 am EST – The current recommendation of Hold for Exxon Mobil Corp (NYSE:XOM) has been derived by using the methods of Louis Navellier for investing and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for the last month. More 

Johnson & Johnson’s (JNJ) Healthy Quant Score Keep it a Buy

Nov. 17, 2017, 10:45 am EST – Johnson & Johnson Co (NYSE:JNJ) is ranked as a Buy using the approach of Louis Navellier for investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking JNJ has had from Portfolio Grader for 8 months. More